To determine the feasibility and toxicity of using prostate-specific membrane antigen-positron emission tomography (PSMA-PET) and multi-parametric magnetic resonance imagining (mpMRI) to guide target volumes for patients with unfavorable-risk prostate cancer receiving radiation.

If you are receiving your cancer treatment at an infusion space in North Carolina Basnight Cancer Hospital (NCBCH), you may be able to take part in a research study. This study aims to understand your satisfaction and experience in the infusion spaces during your treatment.

Have you or your child have been recently diagnosed with cancer? If so, you or your child may be able to take part in a research study looking at how muscle and physical function (strength, mobility, endurance) change in children and young adults undergoing cancer treatment.

Parents are stressed out finding and managing health and nonmedical services for their transition aged children with intellectual and developmental disabilities. Building advocacy skills through peer-to-peer learning provides inspiration and life-long tools to address new questions and needs as they arise. Parents of youth aged 11-27 with IDD are invited to participate in this study. Parents will attend a group with other parents; the groups will meet 4 times, once a week for 1 hour.

The purpose of the study is to better understand how pembrolizumab may work to help your immune system fight your cancer.

The purpose of this study is to determine the extent to which various forms of language exposure affect a second-language Spanish speaker's production of a specific dialectal feature

Do you have asymptomatic multiple myeloma, also known as smoldering multiple myeloma? You may be able to take part in a research study to help us learn more about the effectiveness of a drug called daratumumab in combination with lenalidomide and steroids.

The purpose of this study is to learn how well the combination of two medications (TAK-981 and pembrolizumab) works to treat Select Advanced or Metastatic Solid Tumors. In this study, we will also measure how your body reacts to the combination of medications.

Do you have Leukemia and recent test results show that the signs and symptoms of your cancer have returned? Are you looking for another treatment option? In this study, we want to see if a study medication can treat your cancer.

Have you been diagnosed with high-risk non-muscle invasive bladder cancer which has not responded to initial treatment with Bacillus Calmette-Guerin (BCG)? If so, you may be able to take part in a research study evaluating the safety of adding the study drug called pembrolizumab to an existing treatment option for bladder cancer patients.